Source: Cardiovascular Drugs and Therapy. Unidade: FCF
Subjects: COLESTEROL, BIOMARCADORES, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAMBRANO, Tomás et al. Altered microRNome profiling in statin-induced HepG2 Cells: a pilot study identifying potential new biomarkers involved in lipid-lowering treatment. Cardiovascular Drugs and Therapy, v. 29, n. 6, p. 509-518, 2015Tradução . . Disponível em: https://doi.org/10.1007/s10557-015-6627-0. Acesso em: 09 nov. 2024.APA
Zambrano, T., Hirata, R. D. C., Hirata, M. H., Cerda, A., & Salazar, L. A. (2015). Altered microRNome profiling in statin-induced HepG2 Cells: a pilot study identifying potential new biomarkers involved in lipid-lowering treatment. Cardiovascular Drugs and Therapy, 29( 6), 509-518. doi:10.1007/s10557-015-6627-0NLM
Zambrano T, Hirata RDC, Hirata MH, Cerda A, Salazar LA. Altered microRNome profiling in statin-induced HepG2 Cells: a pilot study identifying potential new biomarkers involved in lipid-lowering treatment [Internet]. Cardiovascular Drugs and Therapy. 2015 ; 29( 6): 509-518.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1007/s10557-015-6627-0Vancouver
Zambrano T, Hirata RDC, Hirata MH, Cerda A, Salazar LA. Altered microRNome profiling in statin-induced HepG2 Cells: a pilot study identifying potential new biomarkers involved in lipid-lowering treatment [Internet]. Cardiovascular Drugs and Therapy. 2015 ; 29( 6): 509-518.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1007/s10557-015-6627-0